SK pharmteco doubles viral vector production capacity in Europe
/PRNewswire/ -- SK pharmteco, SK Inc.'s contract development manufacturing organization (CDMO) for pharmaceuticals, successfully completed its second facility...
Stay updated with breaking news from Source Sk Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- SK pharmteco, SK Inc.'s contract development manufacturing organization (CDMO) for pharmaceuticals, successfully completed its second facility...
/PRNewswire/ -- SK Inc., together with its life science affiliates including SK biopharmaceuticals and SK pharmteco, will hold a networking event to expand...
/PRNewswire/ -- SK Inc., together with its life science affiliates including SK biopharmaceuticals and SK pharmteco, will hold a networking event to expand...
SK Inc. has decided to pay an interim dividend for fifth consecutive year; Despite uncertainties in business environments, SK Inc. maintains its interim dividend at last year's level While focusing on new growth drivers such as advanced materials and biotech, SK Inc. is committed to ensuring business achievements lead to a greater enterprise value SEOUL, South Korea, July 21, 2022 /PRNewswire/ -- SK Inc., the strategic investment arm of South Korea's SK Group, declared an interim dividend for the fifth consecutive year, demonstrating its steadfast commitment to shareholder return. On J...
Press release content from PR Newswire. The AP news staff was not involved in its creation.